Nathalie Pelletier speaks with  Lachlan Hay, Head of Global Network and Communications at Clinuvel AG, and he explains exactly how Scenesse works on vitiligo and thoroughly unravels the FDA trial process which Scenesse will undergo. He also gives us an informative background on Clinuvel, the developers of Scenesse, and describes the stipulations and process one needs to know in order to be a part of the FDA trials for Scenesse.